Evidence map›Paper›PMID 34191173›Full record

ArticleEuropean journal of hybrid imaging2020

Methodological framework for radiomics applications in Hodgkin's lymphoma.

Martina Sollini, Margarita Kirienko, Lara Cavinato, Francesca Ricci, Matteo Biroli, Francesca Ieva, Letizia Calderoni, Elena Tabacchi, Cristina Nanni, Pier Luigi Zinzani and 7 more

Abstract read
In one paragraph

Article in European journal of hybrid imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. A proof of concept study ofScientific reports · 2025
    Article
  3. The predictive power ofAnnals of hematology · 2025
    Article
  4. Review
  5. Article
  6. BaselineDiagnostics (Basel, Switzerland) · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. [EJNMMI research · 2021
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Martina SolliniHumanitas University, Via Rita Levi Montalcini 4, MI 20090, Pieve Emanuele, Italy.ORCID https://orcid.org/0000-0003-2214-6492
Margarita KirienkoHumanitas University, Via Rita Levi Montalcini 4, MI 20090, Pieve Emanuele, Italy. margarita.kirienko@icloud.com.ORCID https://orcid.org/0000-0002-3923-1151
Lara CavinatoHumanitas Clinical and Research Center - IRCCS -, via Manzoni 56, 20089, Rozzano, MI, Italy.
Francesca RicciHumanitas Clinical and Research Center - IRCCS -, via Manzoni 56, 20089, Rozzano, MI, Italy.
Matteo BiroliHumanitas University, Via Rita Levi Montalcini 4, MI 20090, Pieve Emanuele, Italy.ORCID https://orcid.org/0000-0002-3373-7741
Francesca IevaMOX-Modelling and Scientific Computing lab., Department of Mathematics, Politecnico di Milano, Milano, Italy.
Letizia CalderoniNuclear Medicine, AOU S.Orsola-Malpighi, Bologna, Italy.
Elena TabacchiNuclear Medicine, AOU S.Orsola-Malpighi, Bologna, Italy.
Cristina NanniNuclear Medicine, AOU S.Orsola-Malpighi, Bologna, Italy.
Pier Luigi ZinzaniInstitute of Hematology "Seràgnoli", University of Bologna, Bologna, Italy.
Stefano FantiNuclear Medicine, AOU S.Orsola-Malpighi, Bologna, Italy.
Anna GuidettiFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Alessandra AlessiFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Paolo CorradiniFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Ettore SeregniFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Carmelo Carlo-StellaHumanitas University, Via Rita Levi Montalcini 4, MI 20090, Pieve Emanuele, Italy.ORCID https://orcid.org/0000-0003-3144-0124
Arturo ChitiHumanitas University, Via Rita Levi Montalcini 4, MI 20090, Pieve Emanuele, Italy.ORCID https://orcid.org/0000-0002-5806-1856

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccording to published data, radiomics features differ between lesions of refractory/relapsing HL patients from those of long-term responders. However, several methodological aspects have not been elucidated yet. PURPOSE: The study aimed at setting up a methodological framework in radiomics applications in Hodgkin's lymphoma (HL), especially at (a) developing a novel feature selection approach, (b) evaluating radiomic intra-patient lesions' similarity, and (c) classifying relapsing refractory (R/R) vs non-(R/R) patients.

methodsWe retrospectively included 85 patients (male:female = 52:33; median age 35 years, range 19-74). LIFEx (www.lifexsoft.org) was used for [

resultsHL fingerprints included up to 15 features. Intra-patient lesion similarity analysis resulted in mean/median silhouette values below 0.5 (low similarity especially in the non-R/R group). In the test set, the fingerprint_One classification accuracy was 62% (78% sensitivity and 53% specificity); the classification by RUBTE using fingerprint_All resulted in 82% accuracy (70% sensitivity and 88% specificity).

conclusionsLesion similarity analysis was developed, and it allowed to demonstrate that HL lesions were not homogeneous within patients in terms of radiomics signature. Therefore, a random target lesion selection should not be adopted for radiomics applications. Moreover, the classifier to predict R/R vs non-R/R performed the best when all the lesions were used.

Indexed as

Feature selectionLymphomaOutcome predictionPET/CTRadiomicsResponse predictionSilhouetteSimilarity

Identifiers

PMID34191173
PMCPMC8218114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.